Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-05-26

AUTHORS

Edurne San José-Enériz, Xabier Agirre, Obdulia Rabal, Amaia Vilas-Zornoza, Juan A. Sanchez-Arias, Estibaliz Miranda, Ana Ugarte, Sergio Roa, Bruno Paiva, Ander Estella-Hermoso de Mendoza, Rosa María Alvarez, Noelia Casares, Victor Segura, José I. Martín-Subero, François-Xavier Ogi, Pierre Soule, Clara M. Santiveri, Ramón Campos-Olivas, Giancarlo Castellano, Maite Garcia Fernandez de Barrena, Juan Roberto Rodriguez-Madoz, Maria José García-Barchino, Juan Jose Lasarte, Matias A Avila, Jose Angel Martinez-Climent, Julen Oyarzabal, Felipe Prosper

ABSTRACT

The indisputable role of epigenetics in cancer and the fact that epigenetic alterations can be reversed have favoured development of epigenetic drugs. In this study, we design and synthesize potent novel, selective and reversible chemical probes that simultaneously inhibit the G9a and DNMTs methyltransferase activity. In vitro treatment of haematological neoplasia (acute myeloid leukaemia-AML, acute lymphoblastic leukaemia-ALL and diffuse large B-cell lymphoma-DLBCL) with the lead compound CM-272, inhibits cell proliferation and promotes apoptosis, inducing interferon-stimulated genes and immunogenic cell death. CM-272 significantly prolongs survival of AML, ALL and DLBCL xenogeneic models. Our results represent the discovery of first-in-class dual inhibitors of G9a/DNMTs and establish this chemical series as a promising therapeutic tool for unmet needs in haematological tumours. More... »

PAGES

15424

References to SciGraph publications

  • 2014-08-12. The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis in MOLECULAR CANCER
  • 2008-10-26. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes in NATURE STRUCTURAL & MOLECULAR BIOLOGY
  • 2012-01-27. Lysine methyltransferase G9a is not required for DNMT3A/3B anchoring to methylated nucleosomes and maintenance of DNA methylation in somatic cells in EPIGENETICS & CHROMATIN
  • 2012-04-13. Epigenetic protein families: a new frontier for drug discovery in NATURE REVIEWS DRUG DISCOVERY
  • 2014-10-26. Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy in NATURE MEDICINE
  • 2009-02-15. Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294 in NATURE STRUCTURAL & MOLECULAR BIOLOGY
  • 2011-04-10. A diverse array of gene products are effectors of the type I interferon antiviral response in NATURE
  • 2012-02-06. Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia in LEUKEMIA
  • 2013-10-23. Chromatin proteins and modifications as drug targets in NATURE
  • 2011-07-10. A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells in NATURE CHEMICAL BIOLOGY
  • 2006-06-26. 5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation in ONCOGENE
  • Journal

    TITLE

    Nature Communications

    ISSUE

    1

    VOLUME

    8

    Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/ncomms15424

    DOI

    http://dx.doi.org/10.1038/ncomms15424

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1085594512

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/28548080


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Apoptosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Proliferation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Crystallography, X-Ray", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Modification Methylases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dose-Response Relationship, Drug", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Design", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Evaluation, Preclinical", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Enzyme Inhibitors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Epigenesis, Genetic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hematologic Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Histocompatibility Antigens", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Histone-Lysine N-Methyltransferase", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Interferons", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice, Inbred BALB C", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Microsomes, Liver", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Docking Simulation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Survival Analysis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Treatment Outcome", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Xenograft Model Antitumor Assays", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "San Jos\u00e9-En\u00e9riz", 
            "givenName": "Edurne", 
            "id": "sg:person.01370576263.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370576263.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Agirre", 
            "givenName": "Xabier", 
            "id": "sg:person.01227065733.32", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227065733.32"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research, University of Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research, University of Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rabal", 
            "givenName": "Obdulia", 
            "id": "sg:person.01056420451.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056420451.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Vilas-Zornoza", 
            "givenName": "Amaia", 
            "id": "sg:person.01116545321.47", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116545321.47"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research, University of Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research, University of Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sanchez-Arias", 
            "givenName": "Juan A.", 
            "id": "sg:person.015435473274.87", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015435473274.87"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Miranda", 
            "givenName": "Estibaliz", 
            "id": "sg:person.01026574627.20", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026574627.20"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research, University of Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research, University of Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ugarte", 
            "givenName": "Ana", 
            "id": "sg:person.0610325244.79", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610325244.79"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Roa", 
            "givenName": "Sergio", 
            "id": "sg:person.01067161440.85", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067161440.85"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Paiva", 
            "givenName": "Bruno", 
            "id": "sg:person.0631326107.50", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631326107.50"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research, University of Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research, University of Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "de Mendoza", 
            "givenName": "Ander Estella-Hermoso", 
            "id": "sg:person.011640371723.84", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011640371723.84"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research, University of Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research, University of Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Alvarez", 
            "givenName": "Rosa Mar\u00eda", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Area de Terapia G\u00e9nica y Hepatolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Area de Terapia G\u00e9nica y Hepatolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Casares", 
            "givenName": "Noelia", 
            "id": "sg:person.0724550716.02", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724550716.02"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Unidad de Bioinform\u00e1tica, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Unidad de Bioinform\u00e1tica, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Segura", 
            "givenName": "Victor", 
            "id": "sg:person.01331442402.34", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331442402.34"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Departamento de Fundamentos Cl\u00ednicos, Universitat de Barcelona, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, Centre Esther Koplowitz, C/ Rosello 153 2nd floor 08036 Barcelona, Spain", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Departamento de Fundamentos Cl\u00ednicos, Universitat de Barcelona, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, Centre Esther Koplowitz, C/ Rosello 153 2nd floor 08036 Barcelona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mart\u00edn-Subero", 
            "givenName": "Jos\u00e9 I.", 
            "id": "sg:person.01372655533.68", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372655533.68"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Nanotemper Technologies GmbH, Fl\u00f6\u00dfergasse 4, Munich, Germany", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Nanotemper Technologies GmbH, Fl\u00f6\u00dfergasse 4, Munich, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ogi", 
            "givenName": "Fran\u00e7ois-Xavier", 
            "id": "sg:person.0735260127.40", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735260127.40"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Nanotemper Technologies GmbH, Fl\u00f6\u00dfergasse 4, Munich, Germany", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Nanotemper Technologies GmbH, Fl\u00f6\u00dfergasse 4, Munich, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Soule", 
            "givenName": "Pierre", 
            "id": "sg:person.01132240240.27", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132240240.27"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Spectroscopy and NMR Unit, Spanish National Cancer Research Center (CNIO), C/ Melchor Fern\u00e1ndez Almagro, 3 28029 Madrid, Spain", 
              "id": "http://www.grid.ac/institutes/grid.7719.8", 
              "name": [
                "Spectroscopy and NMR Unit, Spanish National Cancer Research Center (CNIO), C/ Melchor Fern\u00e1ndez Almagro, 3 28029 Madrid, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Santiveri", 
            "givenName": "Clara M.", 
            "id": "sg:person.01236341042.01", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236341042.01"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Spectroscopy and NMR Unit, Spanish National Cancer Research Center (CNIO), C/ Melchor Fern\u00e1ndez Almagro, 3 28029 Madrid, Spain", 
              "id": "http://www.grid.ac/institutes/grid.7719.8", 
              "name": [
                "Spectroscopy and NMR Unit, Spanish National Cancer Research Center (CNIO), C/ Melchor Fern\u00e1ndez Almagro, 3 28029 Madrid, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Campos-Olivas", 
            "givenName": "Ram\u00f3n", 
            "id": "sg:person.01203250423.16", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203250423.16"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Departamento de Fundamentos Cl\u00ednicos, Universitat de Barcelona, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, Centre Esther Koplowitz, C/ Rosello 153 2nd floor 08036 Barcelona, Spain", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Departamento de Fundamentos Cl\u00ednicos, Universitat de Barcelona, Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, Centre Esther Koplowitz, C/ Rosello 153 2nd floor 08036 Barcelona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Castellano", 
            "givenName": "Giancarlo", 
            "id": "sg:person.01102155434.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102155434.38"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Area de Terapia G\u00e9nica y Hepatolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Area de Terapia G\u00e9nica y Hepatolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "de Barrena", 
            "givenName": "Maite Garcia Fernandez", 
            "id": "sg:person.013040755427.54", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013040755427.54"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rodriguez-Madoz", 
            "givenName": "Juan Roberto", 
            "id": "sg:person.0753535347.71", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753535347.71"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Garc\u00eda-Barchino", 
            "givenName": "Maria Jos\u00e9", 
            "id": "sg:person.0730345534.62", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730345534.62"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Area de Terapia G\u00e9nica y Hepatolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Area de Terapia G\u00e9nica y Hepatolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lasarte", 
            "givenName": "Juan Jose", 
            "id": "sg:person.0677451336.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677451336.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Area de Terapia G\u00e9nica y Hepatolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Area de Terapia G\u00e9nica y Hepatolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Avila", 
            "givenName": "Matias A", 
            "id": "sg:person.012321307677.82", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012321307677.82"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Martinez-Climent", 
            "givenName": "Jose Angel", 
            "id": "sg:person.013455437154.78", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013455437154.78"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research, University of Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.5924.a", 
              "name": [
                "Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research, University of Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Oyarzabal", 
            "givenName": "Julen", 
            "id": "sg:person.01130401777.54", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130401777.54"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Departamento de Hematolog\u00eda, Cl\u00ednica Universidad de Navarra, Universidad de Navarra, Avenida P\u00edo XII, 36 31008 Pamplona, Spain", 
              "id": "http://www.grid.ac/institutes/grid.411730.0", 
              "name": [
                "Area de Hemato-Oncolog\u00eda, Centro de Investigaci\u00f3n M\u00e9dica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida P\u00edo XII, 55 31008 Pamplona, Spain", 
                "Departamento de Hematolog\u00eda, Cl\u00ednica Universidad de Navarra, Universidad de Navarra, Avenida P\u00edo XII, 36 31008 Pamplona, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Prosper", 
            "givenName": "Felipe", 
            "id": "sg:person.01262144070.75", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262144070.75"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/sj.onc.1209763", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018340335", 
              "https://doi.org/10.1038/sj.onc.1209763"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/leu.2012.31", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031162923", 
              "https://doi.org/10.1038/leu.2012.31"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1756-8935-5-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012361620", 
              "https://doi.org/10.1186/1756-8935-5-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd3674", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007920084", 
              "https://doi.org/10.1038/nrd3674"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nsmb.1476", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014235384", 
              "https://doi.org/10.1038/nsmb.1476"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1476-4598-13-189", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032693197", 
              "https://doi.org/10.1186/1476-4598-13-189"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm.3708", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034226043", 
              "https://doi.org/10.1038/nm.3708"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nsmb.1560", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030525601", 
              "https://doi.org/10.1038/nsmb.1560"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nchembio.599", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002547330", 
              "https://doi.org/10.1038/nchembio.599"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature09907", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017695268", 
              "https://doi.org/10.1038/nature09907"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature12751", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027763738", 
              "https://doi.org/10.1038/nature12751"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2017-05-26", 
        "datePublishedReg": "2017-05-26", 
        "description": "The indisputable role of epigenetics in cancer and the fact that epigenetic alterations can be reversed have favoured development of epigenetic drugs. In this study, we design and synthesize potent novel, selective and reversible chemical probes that simultaneously inhibit the G9a and DNMTs methyltransferase activity. In vitro treatment of haematological neoplasia (acute myeloid leukaemia-AML, acute lymphoblastic leukaemia-ALL and diffuse large B-cell lymphoma-DLBCL) with the lead compound CM-272, inhibits cell proliferation and promotes apoptosis, inducing interferon-stimulated genes and immunogenic cell death. CM-272 significantly prolongs survival of AML, ALL and DLBCL xenogeneic models. Our results represent the discovery of first-in-class dual inhibitors of G9a/DNMTs and establish this chemical series as a promising therapeutic tool for unmet needs in haematological tumours.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/ncomms15424", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.8098860", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.8099233", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.3796817", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1043282", 
            "issn": [
              "2041-1723"
            ], 
            "name": "Nature Communications", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "8"
          }
        ], 
        "keywords": [
          "dual small molecule inhibitors", 
          "chemical probes", 
          "chemical series", 
          "potent novel", 
          "immunogenic cell death", 
          "promising therapeutic tool", 
          "interferon-stimulated genes", 
          "inhibits cell proliferation", 
          "prolong survival", 
          "class dual inhibitor", 
          "xenogeneic model", 
          "haematological tumours", 
          "hematological malignancies", 
          "vitro treatment", 
          "small molecule inhibitors", 
          "unmet need", 
          "haematological neoplasias", 
          "therapeutic tool", 
          "dual inhibitor", 
          "cell proliferation", 
          "molecule inhibitors", 
          "epigenetic drugs", 
          "cell death", 
          "epigenetic alterations", 
          "inhibitors", 
          "malignancy", 
          "DNMTs", 
          "neoplasia", 
          "methyltransferase activity", 
          "AML", 
          "tumors", 
          "cancer", 
          "drugs", 
          "discovery", 
          "death", 
          "survival", 
          "probe", 
          "treatment", 
          "apoptosis", 
          "proliferation", 
          "alterations", 
          "G9a", 
          "indisputable role", 
          "series", 
          "novel", 
          "activity", 
          "epigenetics", 
          "study", 
          "role", 
          "genes", 
          "need", 
          "development", 
          "results", 
          "tool", 
          "model", 
          "fact", 
          "reversible chemical probes", 
          "DNMTs methyltransferase activity", 
          "lead compound CM-272", 
          "compound CM-272", 
          "CM-272", 
          "DLBCL xenogeneic models", 
          "G9a/DNMTs", 
          "class reversible dual small molecule inhibitors", 
          "reversible dual small molecule inhibitors"
        ], 
        "name": "Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies", 
        "pagination": "15424", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1085594512"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/ncomms15424"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "28548080"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/ncomms15424", 
          "https://app.dimensions.ai/details/publication/pub.1085594512"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-12-01T19:41", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_755.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/ncomms15424"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/ncomms15424'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/ncomms15424'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/ncomms15424'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/ncomms15424'


     

    This table displays all metadata directly associated to this object as RDF triples.

    475 TRIPLES      22 PREDICATES      127 URIs      108 LITERALS      32 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/ncomms15424 schema:about N0076839a10ba43c3968682886961883a
    2 N13ee40bb24844b2fa0696557c1e3193e
    3 N17126701fb1542d6a868ae09cd8b92fc
    4 N1e46ad4f9dc944b48b8c4ee2531c90c2
    5 N20283b8f2b854ffc8667aadac3491a94
    6 N29f6aa0e549b44cbac6fa6994acb53f6
    7 N3fc75068ca88446f9fa9ffafd9588245
    8 N411dfbda75ed4dea9dde112026cc77ea
    9 N43e29b139722449ab5854ca1a30d28f0
    10 N479f81aadc404e08a2b990c43b7ba9c5
    11 N4ebf47bee68e42398aadbe0c8a41865c
    12 N61b36cb6091342ed8c0b5605936ed803
    13 N70c21fd336ca49c2957868532851b994
    14 N82cb8a0a8aea4ecf90def4a145bc8b06
    15 N8bc0fdd61a00404ea13be08ae4514c08
    16 N9ad960be4c6d4c8180a254e05e219c8a
    17 N9dd3ab42159b4319ae6c8f6eb0327113
    18 Na0f103b6f8f144a98d6f66c1b0d77b78
    19 Nb3a8e6eb0b6b4cef98e01ff42ca0b9f8
    20 Nb446cdcb84fc40d6bd18806fb3841123
    21 Nb4dae1806a8047e183a11eb186622801
    22 Nc306546e190744359781545fc1b18d3a
    23 Ndc4cc571694e45248510dd977290e204
    24 Ne2b229dd276d4a85aba8e0f43b0803e3
    25 Nefa1142747fe4ad7a433e0c6d13126c0
    26 anzsrc-for:11
    27 anzsrc-for:1112
    28 schema:author Ned7c8350599243f59d59c95ae87f9ba2
    29 schema:citation sg:pub.10.1038/leu.2012.31
    30 sg:pub.10.1038/nature09907
    31 sg:pub.10.1038/nature12751
    32 sg:pub.10.1038/nchembio.599
    33 sg:pub.10.1038/nm.3708
    34 sg:pub.10.1038/nrd3674
    35 sg:pub.10.1038/nsmb.1476
    36 sg:pub.10.1038/nsmb.1560
    37 sg:pub.10.1038/sj.onc.1209763
    38 sg:pub.10.1186/1476-4598-13-189
    39 sg:pub.10.1186/1756-8935-5-3
    40 schema:datePublished 2017-05-26
    41 schema:datePublishedReg 2017-05-26
    42 schema:description The indisputable role of epigenetics in cancer and the fact that epigenetic alterations can be reversed have favoured development of epigenetic drugs. In this study, we design and synthesize potent novel, selective and reversible chemical probes that simultaneously inhibit the G9a and DNMTs methyltransferase activity. In vitro treatment of haematological neoplasia (acute myeloid leukaemia-AML, acute lymphoblastic leukaemia-ALL and diffuse large B-cell lymphoma-DLBCL) with the lead compound CM-272, inhibits cell proliferation and promotes apoptosis, inducing interferon-stimulated genes and immunogenic cell death. CM-272 significantly prolongs survival of AML, ALL and DLBCL xenogeneic models. Our results represent the discovery of first-in-class dual inhibitors of G9a/DNMTs and establish this chemical series as a promising therapeutic tool for unmet needs in haematological tumours.
    43 schema:genre article
    44 schema:inLanguage en
    45 schema:isAccessibleForFree true
    46 schema:isPartOf N1206d604a50843e8a598f5881d8948b7
    47 N963eeafef9564d4facdaa4106d29083e
    48 sg:journal.1043282
    49 schema:keywords AML
    50 CM-272
    51 DLBCL xenogeneic models
    52 DNMTs
    53 DNMTs methyltransferase activity
    54 G9a
    55 G9a/DNMTs
    56 activity
    57 alterations
    58 apoptosis
    59 cancer
    60 cell death
    61 cell proliferation
    62 chemical probes
    63 chemical series
    64 class dual inhibitor
    65 class reversible dual small molecule inhibitors
    66 compound CM-272
    67 death
    68 development
    69 discovery
    70 drugs
    71 dual inhibitor
    72 dual small molecule inhibitors
    73 epigenetic alterations
    74 epigenetic drugs
    75 epigenetics
    76 fact
    77 genes
    78 haematological neoplasias
    79 haematological tumours
    80 hematological malignancies
    81 immunogenic cell death
    82 indisputable role
    83 inhibitors
    84 inhibits cell proliferation
    85 interferon-stimulated genes
    86 lead compound CM-272
    87 malignancy
    88 methyltransferase activity
    89 model
    90 molecule inhibitors
    91 need
    92 neoplasia
    93 novel
    94 potent novel
    95 probe
    96 proliferation
    97 prolong survival
    98 promising therapeutic tool
    99 results
    100 reversible chemical probes
    101 reversible dual small molecule inhibitors
    102 role
    103 series
    104 small molecule inhibitors
    105 study
    106 survival
    107 therapeutic tool
    108 tool
    109 treatment
    110 tumors
    111 unmet need
    112 vitro treatment
    113 xenogeneic model
    114 schema:name Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
    115 schema:pagination 15424
    116 schema:productId N11e44de8913f40d3b81018b3f3a17179
    117 N555ef516076a4fe08e863b76aaa47bf8
    118 N6cfdeca5024c49dabc60453789dbcb74
    119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085594512
    120 https://doi.org/10.1038/ncomms15424
    121 schema:sdDatePublished 2021-12-01T19:41
    122 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    123 schema:sdPublisher N54adf06e26cd49ec84cffb895cd5d98a
    124 schema:url https://doi.org/10.1038/ncomms15424
    125 sgo:license sg:explorer/license/
    126 sgo:sdDataset articles
    127 rdf:type schema:ScholarlyArticle
    128 N0076839a10ba43c3968682886961883a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Epigenesis, Genetic
    130 rdf:type schema:DefinedTerm
    131 N04e46bb9ec5049f993f3820b3ee1d500 rdf:first sg:person.01203250423.16
    132 rdf:rest Na0c46c87fd9e49a99d37a1bdef3340ec
    133 N0937ec118c2e4ebfb9363f984ab3c9a0 rdf:first sg:person.01056420451.08
    134 rdf:rest N41e9e9f9100d453c812667c5e06b412c
    135 N11e44de8913f40d3b81018b3f3a17179 schema:name pubmed_id
    136 schema:value 28548080
    137 rdf:type schema:PropertyValue
    138 N1206d604a50843e8a598f5881d8948b7 schema:volumeNumber 8
    139 rdf:type schema:PublicationVolume
    140 N13ee40bb24844b2fa0696557c1e3193e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Humans
    142 rdf:type schema:DefinedTerm
    143 N17126701fb1542d6a868ae09cd8b92fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Cell Proliferation
    145 rdf:type schema:DefinedTerm
    146 N18d0939199324f46ac14360aefbe2b03 rdf:first sg:person.0610325244.79
    147 rdf:rest N6ecc1b68645546738c6905becf30885c
    148 N1e46ad4f9dc944b48b8c4ee2531c90c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    149 schema:name Apoptosis
    150 rdf:type schema:DefinedTerm
    151 N20283b8f2b854ffc8667aadac3491a94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Drug Design
    153 rdf:type schema:DefinedTerm
    154 N29f6aa0e549b44cbac6fa6994acb53f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Enzyme Inhibitors
    156 rdf:type schema:DefinedTerm
    157 N2a13ceefdf0947c5bc0cceb66540311c rdf:first sg:person.01227065733.32
    158 rdf:rest N0937ec118c2e4ebfb9363f984ab3c9a0
    159 N308551246aa1495f8b34949b1d40a05f rdf:first sg:person.01026574627.20
    160 rdf:rest N18d0939199324f46ac14360aefbe2b03
    161 N342c14aad0a44144b0cf969cc089a081 rdf:first sg:person.0631326107.50
    162 rdf:rest N3a5319b172534469b8ff7c12fabbdf60
    163 N3a5319b172534469b8ff7c12fabbdf60 rdf:first sg:person.011640371723.84
    164 rdf:rest Nfcc54f76936c494c93314e3fb4ce44a1
    165 N3fc75068ca88446f9fa9ffafd9588245 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Survival Analysis
    167 rdf:type schema:DefinedTerm
    168 N411dfbda75ed4dea9dde112026cc77ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Cell Line, Tumor
    170 rdf:type schema:DefinedTerm
    171 N41e9e9f9100d453c812667c5e06b412c rdf:first sg:person.01116545321.47
    172 rdf:rest Nc4503048f5dc4663b90a3cb8e69baafe
    173 N43e29b139722449ab5854ca1a30d28f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Female
    175 rdf:type schema:DefinedTerm
    176 N479f81aadc404e08a2b990c43b7ba9c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    177 schema:name Dose-Response Relationship, Drug
    178 rdf:type schema:DefinedTerm
    179 N4ebf47bee68e42398aadbe0c8a41865c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    180 schema:name Histocompatibility Antigens
    181 rdf:type schema:DefinedTerm
    182 N510d874c8a984d1195bb56fd2c1c1f55 rdf:first sg:person.01236341042.01
    183 rdf:rest N04e46bb9ec5049f993f3820b3ee1d500
    184 N54adf06e26cd49ec84cffb895cd5d98a schema:name Springer Nature - SN SciGraph project
    185 rdf:type schema:Organization
    186 N555ef516076a4fe08e863b76aaa47bf8 schema:name doi
    187 schema:value 10.1038/ncomms15424
    188 rdf:type schema:PropertyValue
    189 N61b36cb6091342ed8c0b5605936ed803 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    190 schema:name Antineoplastic Agents
    191 rdf:type schema:DefinedTerm
    192 N664c1ee5ec5a46a2b61786bd6b1c3a43 rdf:first sg:person.013040755427.54
    193 rdf:rest Ndd7dca4714dd423d80d24b7db9bcaff9
    194 N6a51949b50994bc3a0a29500c8520ee1 rdf:first sg:person.01331442402.34
    195 rdf:rest Nef44856c03a94ea69bfe59e127ae865d
    196 N6cfdeca5024c49dabc60453789dbcb74 schema:name dimensions_id
    197 schema:value pub.1085594512
    198 rdf:type schema:PropertyValue
    199 N6ecc1b68645546738c6905becf30885c rdf:first sg:person.01067161440.85
    200 rdf:rest N342c14aad0a44144b0cf969cc089a081
    201 N70c21fd336ca49c2957868532851b994 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    202 schema:name Mice
    203 rdf:type schema:DefinedTerm
    204 N7393fb0b6eb64d29b1a8ed3c18a7224a rdf:first sg:person.01132240240.27
    205 rdf:rest N510d874c8a984d1195bb56fd2c1c1f55
    206 N806ec72cf851405280ee0e61d21cc2f4 rdf:first sg:person.0735260127.40
    207 rdf:rest N7393fb0b6eb64d29b1a8ed3c18a7224a
    208 N82cb8a0a8aea4ecf90def4a145bc8b06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    209 schema:name Mice, Inbred BALB C
    210 rdf:type schema:DefinedTerm
    211 N8bc0fdd61a00404ea13be08ae4514c08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    212 schema:name Animals
    213 rdf:type schema:DefinedTerm
    214 N963eeafef9564d4facdaa4106d29083e schema:issueNumber 1
    215 rdf:type schema:PublicationIssue
    216 N9ad960be4c6d4c8180a254e05e219c8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    217 schema:name Crystallography, X-Ray
    218 rdf:type schema:DefinedTerm
    219 N9dd3ab42159b4319ae6c8f6eb0327113 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    220 schema:name DNA Modification Methylases
    221 rdf:type schema:DefinedTerm
    222 Na0c46c87fd9e49a99d37a1bdef3340ec rdf:first sg:person.01102155434.38
    223 rdf:rest N664c1ee5ec5a46a2b61786bd6b1c3a43
    224 Na0f103b6f8f144a98d6f66c1b0d77b78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    225 schema:name Xenograft Model Antitumor Assays
    226 rdf:type schema:DefinedTerm
    227 Na2656556610c4ad4b3824dd1b18db2db schema:affiliation grid-institutes:grid.5924.a
    228 schema:familyName Alvarez
    229 schema:givenName Rosa María
    230 rdf:type schema:Person
    231 Na5e6c95825e74d8ba2a50a00e75bdd90 rdf:first sg:person.0677451336.13
    232 rdf:rest Ndb978b32aaf54e06b0b4af36b058e02c
    233 Nb17835d626ed4e258ba8a3c5571019e8 rdf:first sg:person.0724550716.02
    234 rdf:rest N6a51949b50994bc3a0a29500c8520ee1
    235 Nb3a8e6eb0b6b4cef98e01ff42ca0b9f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    236 schema:name Histone-Lysine N-Methyltransferase
    237 rdf:type schema:DefinedTerm
    238 Nb446cdcb84fc40d6bd18806fb3841123 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    239 schema:name Interferons
    240 rdf:type schema:DefinedTerm
    241 Nb4dae1806a8047e183a11eb186622801 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    242 schema:name Treatment Outcome
    243 rdf:type schema:DefinedTerm
    244 Nb696ea8034a442168bf6a7b47d0b0079 rdf:first sg:person.013455437154.78
    245 rdf:rest Ndefc18be736542aab58eea2cbc632786
    246 Nc306546e190744359781545fc1b18d3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    247 schema:name Molecular Docking Simulation
    248 rdf:type schema:DefinedTerm
    249 Nc4503048f5dc4663b90a3cb8e69baafe rdf:first sg:person.015435473274.87
    250 rdf:rest N308551246aa1495f8b34949b1d40a05f
    251 Ndb978b32aaf54e06b0b4af36b058e02c rdf:first sg:person.012321307677.82
    252 rdf:rest Nb696ea8034a442168bf6a7b47d0b0079
    253 Ndc4cc571694e45248510dd977290e204 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    254 schema:name Microsomes, Liver
    255 rdf:type schema:DefinedTerm
    256 Ndd7dca4714dd423d80d24b7db9bcaff9 rdf:first sg:person.0753535347.71
    257 rdf:rest Ne28f65322cd541c79ae6672b04e9402b
    258 Ndefc18be736542aab58eea2cbc632786 rdf:first sg:person.01130401777.54
    259 rdf:rest Ne803ab8b8660417dbff5429a912295db
    260 Ne28f65322cd541c79ae6672b04e9402b rdf:first sg:person.0730345534.62
    261 rdf:rest Na5e6c95825e74d8ba2a50a00e75bdd90
    262 Ne2b229dd276d4a85aba8e0f43b0803e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    263 schema:name Drug Evaluation, Preclinical
    264 rdf:type schema:DefinedTerm
    265 Ne803ab8b8660417dbff5429a912295db rdf:first sg:person.01262144070.75
    266 rdf:rest rdf:nil
    267 Ned7c8350599243f59d59c95ae87f9ba2 rdf:first sg:person.01370576263.22
    268 rdf:rest N2a13ceefdf0947c5bc0cceb66540311c
    269 Nef44856c03a94ea69bfe59e127ae865d rdf:first sg:person.01372655533.68
    270 rdf:rest N806ec72cf851405280ee0e61d21cc2f4
    271 Nefa1142747fe4ad7a433e0c6d13126c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    272 schema:name Hematologic Neoplasms
    273 rdf:type schema:DefinedTerm
    274 Nfcc54f76936c494c93314e3fb4ce44a1 rdf:first Na2656556610c4ad4b3824dd1b18db2db
    275 rdf:rest Nb17835d626ed4e258ba8a3c5571019e8
    276 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    277 schema:name Medical and Health Sciences
    278 rdf:type schema:DefinedTerm
    279 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    280 schema:name Oncology and Carcinogenesis
    281 rdf:type schema:DefinedTerm
    282 sg:grant.3796817 http://pending.schema.org/fundedItem sg:pub.10.1038/ncomms15424
    283 rdf:type schema:MonetaryGrant
    284 sg:grant.8098860 http://pending.schema.org/fundedItem sg:pub.10.1038/ncomms15424
    285 rdf:type schema:MonetaryGrant
    286 sg:grant.8099233 http://pending.schema.org/fundedItem sg:pub.10.1038/ncomms15424
    287 rdf:type schema:MonetaryGrant
    288 sg:journal.1043282 schema:issn 2041-1723
    289 schema:name Nature Communications
    290 schema:publisher Springer Nature
    291 rdf:type schema:Periodical
    292 sg:person.01026574627.20 schema:affiliation grid-institutes:grid.5924.a
    293 schema:familyName Miranda
    294 schema:givenName Estibaliz
    295 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026574627.20
    296 rdf:type schema:Person
    297 sg:person.01056420451.08 schema:affiliation grid-institutes:grid.5924.a
    298 schema:familyName Rabal
    299 schema:givenName Obdulia
    300 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01056420451.08
    301 rdf:type schema:Person
    302 sg:person.01067161440.85 schema:affiliation grid-institutes:grid.5924.a
    303 schema:familyName Roa
    304 schema:givenName Sergio
    305 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01067161440.85
    306 rdf:type schema:Person
    307 sg:person.01102155434.38 schema:affiliation grid-institutes:None
    308 schema:familyName Castellano
    309 schema:givenName Giancarlo
    310 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102155434.38
    311 rdf:type schema:Person
    312 sg:person.01116545321.47 schema:affiliation grid-institutes:grid.5924.a
    313 schema:familyName Vilas-Zornoza
    314 schema:givenName Amaia
    315 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116545321.47
    316 rdf:type schema:Person
    317 sg:person.01130401777.54 schema:affiliation grid-institutes:grid.5924.a
    318 schema:familyName Oyarzabal
    319 schema:givenName Julen
    320 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130401777.54
    321 rdf:type schema:Person
    322 sg:person.01132240240.27 schema:affiliation grid-institutes:None
    323 schema:familyName Soule
    324 schema:givenName Pierre
    325 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132240240.27
    326 rdf:type schema:Person
    327 sg:person.011640371723.84 schema:affiliation grid-institutes:grid.5924.a
    328 schema:familyName de Mendoza
    329 schema:givenName Ander Estella-Hermoso
    330 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011640371723.84
    331 rdf:type schema:Person
    332 sg:person.01203250423.16 schema:affiliation grid-institutes:grid.7719.8
    333 schema:familyName Campos-Olivas
    334 schema:givenName Ramón
    335 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203250423.16
    336 rdf:type schema:Person
    337 sg:person.01227065733.32 schema:affiliation grid-institutes:grid.5924.a
    338 schema:familyName Agirre
    339 schema:givenName Xabier
    340 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01227065733.32
    341 rdf:type schema:Person
    342 sg:person.012321307677.82 schema:affiliation grid-institutes:grid.5924.a
    343 schema:familyName Avila
    344 schema:givenName Matias A
    345 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012321307677.82
    346 rdf:type schema:Person
    347 sg:person.01236341042.01 schema:affiliation grid-institutes:grid.7719.8
    348 schema:familyName Santiveri
    349 schema:givenName Clara M.
    350 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236341042.01
    351 rdf:type schema:Person
    352 sg:person.01262144070.75 schema:affiliation grid-institutes:grid.411730.0
    353 schema:familyName Prosper
    354 schema:givenName Felipe
    355 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01262144070.75
    356 rdf:type schema:Person
    357 sg:person.013040755427.54 schema:affiliation grid-institutes:grid.5924.a
    358 schema:familyName de Barrena
    359 schema:givenName Maite Garcia Fernandez
    360 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013040755427.54
    361 rdf:type schema:Person
    362 sg:person.01331442402.34 schema:affiliation grid-institutes:grid.5924.a
    363 schema:familyName Segura
    364 schema:givenName Victor
    365 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01331442402.34
    366 rdf:type schema:Person
    367 sg:person.013455437154.78 schema:affiliation grid-institutes:grid.5924.a
    368 schema:familyName Martinez-Climent
    369 schema:givenName Jose Angel
    370 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013455437154.78
    371 rdf:type schema:Person
    372 sg:person.01370576263.22 schema:affiliation grid-institutes:grid.5924.a
    373 schema:familyName San José-Enériz
    374 schema:givenName Edurne
    375 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01370576263.22
    376 rdf:type schema:Person
    377 sg:person.01372655533.68 schema:affiliation grid-institutes:None
    378 schema:familyName Martín-Subero
    379 schema:givenName José I.
    380 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372655533.68
    381 rdf:type schema:Person
    382 sg:person.015435473274.87 schema:affiliation grid-institutes:grid.5924.a
    383 schema:familyName Sanchez-Arias
    384 schema:givenName Juan A.
    385 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015435473274.87
    386 rdf:type schema:Person
    387 sg:person.0610325244.79 schema:affiliation grid-institutes:grid.5924.a
    388 schema:familyName Ugarte
    389 schema:givenName Ana
    390 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610325244.79
    391 rdf:type schema:Person
    392 sg:person.0631326107.50 schema:affiliation grid-institutes:grid.5924.a
    393 schema:familyName Paiva
    394 schema:givenName Bruno
    395 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631326107.50
    396 rdf:type schema:Person
    397 sg:person.0677451336.13 schema:affiliation grid-institutes:grid.5924.a
    398 schema:familyName Lasarte
    399 schema:givenName Juan Jose
    400 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0677451336.13
    401 rdf:type schema:Person
    402 sg:person.0724550716.02 schema:affiliation grid-institutes:grid.5924.a
    403 schema:familyName Casares
    404 schema:givenName Noelia
    405 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724550716.02
    406 rdf:type schema:Person
    407 sg:person.0730345534.62 schema:affiliation grid-institutes:grid.5924.a
    408 schema:familyName García-Barchino
    409 schema:givenName Maria José
    410 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0730345534.62
    411 rdf:type schema:Person
    412 sg:person.0735260127.40 schema:affiliation grid-institutes:None
    413 schema:familyName Ogi
    414 schema:givenName François-Xavier
    415 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735260127.40
    416 rdf:type schema:Person
    417 sg:person.0753535347.71 schema:affiliation grid-institutes:grid.5924.a
    418 schema:familyName Rodriguez-Madoz
    419 schema:givenName Juan Roberto
    420 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0753535347.71
    421 rdf:type schema:Person
    422 sg:pub.10.1038/leu.2012.31 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031162923
    423 https://doi.org/10.1038/leu.2012.31
    424 rdf:type schema:CreativeWork
    425 sg:pub.10.1038/nature09907 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017695268
    426 https://doi.org/10.1038/nature09907
    427 rdf:type schema:CreativeWork
    428 sg:pub.10.1038/nature12751 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027763738
    429 https://doi.org/10.1038/nature12751
    430 rdf:type schema:CreativeWork
    431 sg:pub.10.1038/nchembio.599 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002547330
    432 https://doi.org/10.1038/nchembio.599
    433 rdf:type schema:CreativeWork
    434 sg:pub.10.1038/nm.3708 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034226043
    435 https://doi.org/10.1038/nm.3708
    436 rdf:type schema:CreativeWork
    437 sg:pub.10.1038/nrd3674 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007920084
    438 https://doi.org/10.1038/nrd3674
    439 rdf:type schema:CreativeWork
    440 sg:pub.10.1038/nsmb.1476 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014235384
    441 https://doi.org/10.1038/nsmb.1476
    442 rdf:type schema:CreativeWork
    443 sg:pub.10.1038/nsmb.1560 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030525601
    444 https://doi.org/10.1038/nsmb.1560
    445 rdf:type schema:CreativeWork
    446 sg:pub.10.1038/sj.onc.1209763 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018340335
    447 https://doi.org/10.1038/sj.onc.1209763
    448 rdf:type schema:CreativeWork
    449 sg:pub.10.1186/1476-4598-13-189 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032693197
    450 https://doi.org/10.1186/1476-4598-13-189
    451 rdf:type schema:CreativeWork
    452 sg:pub.10.1186/1756-8935-5-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012361620
    453 https://doi.org/10.1186/1756-8935-5-3
    454 rdf:type schema:CreativeWork
    455 grid-institutes:None schema:alternateName Departamento de Fundamentos Clínicos, Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centre Esther Koplowitz, C/ Rosello 153 2nd floor 08036 Barcelona, Spain
    456 Nanotemper Technologies GmbH, Flößergasse 4, Munich, Germany
    457 schema:name Departamento de Fundamentos Clínicos, Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centre Esther Koplowitz, C/ Rosello 153 2nd floor 08036 Barcelona, Spain
    458 Nanotemper Technologies GmbH, Flößergasse 4, Munich, Germany
    459 rdf:type schema:Organization
    460 grid-institutes:grid.411730.0 schema:alternateName Departamento de Hematología, Clínica Universidad de Navarra, Universidad de Navarra, Avenida Pío XII, 36 31008 Pamplona, Spain
    461 schema:name Area de Hemato-Oncología, Centro de Investigación Médica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida Pío XII, 55 31008 Pamplona, Spain
    462 Departamento de Hematología, Clínica Universidad de Navarra, Universidad de Navarra, Avenida Pío XII, 36 31008 Pamplona, Spain
    463 rdf:type schema:Organization
    464 grid-institutes:grid.5924.a schema:alternateName Area de Hemato-Oncología, Centro de Investigación Médica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida Pío XII, 55 31008 Pamplona, Spain
    465 Area de Terapia Génica y Hepatología, Centro de Investigación Médica Aplicada, Universidad de Navarra, Avenida Pío XII, 55 31008 Pamplona, Spain
    466 Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research, University of Navarra, Avenida Pío XII, 55 31008 Pamplona, Spain
    467 Unidad de Bioinformática, Centro de Investigación Médica Aplicada, Universidad de Navarra, Avenida Pío XII, 55 31008 Pamplona, Spain
    468 schema:name Area de Hemato-Oncología, Centro de Investigación Médica Aplicada, IDISNA, Ciberonc, Universidad de Navarra, Avenida Pío XII, 55 31008 Pamplona, Spain
    469 Area de Terapia Génica y Hepatología, Centro de Investigación Médica Aplicada, Universidad de Navarra, Avenida Pío XII, 55 31008 Pamplona, Spain
    470 Small Molecule Discovery Platform, Molecular Therapeutics Program, Center for Applied Medical Research, University of Navarra, Avenida Pío XII, 55 31008 Pamplona, Spain
    471 Unidad de Bioinformática, Centro de Investigación Médica Aplicada, Universidad de Navarra, Avenida Pío XII, 55 31008 Pamplona, Spain
    472 rdf:type schema:Organization
    473 grid-institutes:grid.7719.8 schema:alternateName Spectroscopy and NMR Unit, Spanish National Cancer Research Center (CNIO), C/ Melchor Fernández Almagro, 3 28029 Madrid, Spain
    474 schema:name Spectroscopy and NMR Unit, Spanish National Cancer Research Center (CNIO), C/ Melchor Fernández Almagro, 3 28029 Madrid, Spain
    475 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...